Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure

Kardiologia Polska

Volumn 66, Issue 4, 2008, Pages 406-412

  Chwyczko, Tomasz ^a   Sterliński, Maciej ^a   Macia̧g, Aleksander ^a   Firek, Bohdan ^a   Łabȩcka, Andrada ^a   Jankowska, Agnieszka ^a   Kośmicki, Marek ^a   Kowalik, Ilona ^a   Malczewska, Beata ^a   Szwed, Hanna ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Cardiopulmonary exercise test; Chronic heart failure; Exercise tolerance; Resynchronisation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON DIOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; OXYGEN; SPIRONOLACTONE;

ADAPTATION; ADULT; ARTICLE; BLOOD PRESSURE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DEVICE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; GAS ANALYSIS; HEART BEAT; HEART FAILURE; HEART RATE; HUMAN; LUNG MINUTE VOLUME; MALE; OXYGEN CONSUMPTION; RATING SCALE; RESPIRATORY SYSTEM; SYMPTOM; WALKING; AGED; ARTIFICIAL HEART PACEMAKER; CHRONIC DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; HEART PACING; HOSPITALIZATION; MIDDLE AGED; TREATMENT OUTCOME;

AGED; CARDIAC PACING, ARTIFICIAL; CHRONIC DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WALKING;

EID: 50049084759     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Remme WJ, Swedberg K; Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.
2. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22: 6A-13A.
3. Deedwania PC, Carbajal EV. Current diagnosis and treatment in cardiology, In: Congestive Heart Failure, Appleton and Lange, 1995. (p. 183), In: Crawford M (ed.). Current Diagnosis &Treatment in Cardiology. Lange/McGraw-Hill, 2002.
4. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005; 46: 2183-92.
5. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002; 39: 2026-33.
6. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002; 40: 111-8.
7. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42: 1454-9.
8. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. N Engl J Med 2002; 346: 1845-53.
9. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail 2000; 6: 276-85.
10. Cleland JG, Daubert JC, Erdmann E, et al.; Cardiac Resynchronization- Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
11. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-40.
12. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Card 2005; 46: e1-82.
13. Auricchio A, Stellbrink C, Butter C, et al.; Pacing Therapies in Congestive Heart Failure II Study Group; Guidant Heart Failure Research Group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003; 42: 2109-16.
14. Corra U, Mezzani A, Bosimini E, et al. Cardiopulmonary exercise testing and prognosis in chronic heart failure: a prognosticating algorithm for the individual patient. Chest 2004; 126: 942-50.
15. Francis DP, Shamim W, Davies LC, et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J 2000; 21: 154-61.
16. Stelbrink C, Auricchio A, Lemke B, et al. Policy paper to the cardiac re-sychronization therapy]. Z Kardiol 2003; 92: 96-103.
17. Auricchio A, Stellbrink C, Sack S, et al. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999; 83: 130D-135D.
18. Contak CD subanalysis: www.fda.org. Contak CD CRT-D system. Summary of safety and effectiveness.
19. Lamp B, Vogt J, Schmidt H, et al. Impact of cardiopulmonary exercise testing on patient selection for cardiac resynchronisation therapy. Eur Heart J Suppl 2004; 6: D5-D9.
20. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103: 916-18.
21. Francis DP, Shamim W, Davies LC, et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J 2000; 21: 154-61.
22. Ponikowski P, Chua TP, Anker SD et al. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 2001; 104: 544-9.
23. Ponikowski PP, Chua TP, Francis DP et al. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation 2001; 104: 2324-30.